Who makes Maalox Advance Regular Strength liquid?

Maalox Advance Regular Strength liquid is developed by Takeda.

What development phase is Maalox Advance Regular Strength liquid in?

Maalox Advance Regular Strength liquid is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Maalox Advance Regular Strength liquid

Takeda · Phase 1 active Small molecule

At a glance

Generic name	Maalox Advance Regular Strength liquid
Sponsor	Takeda
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Maalox Advance Regular Strength liquid CI brief — competitive landscape report
Maalox Advance Regular Strength liquid updates RSS · CI watch RSS
Takeda portfolio CI